American Journal of Psychiatry · 1980 · 301 citations · 11 references
MedicinePharmacologyPsychiatryNeuropharmacologyNeuropsychiatryPsychopharmacologyAntipsychotic PharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapyDopaminergic PharmacologyNeuropsychiatric DisordersAntipsychotic-induced Tardive Dyskinesia
Tardive dyskinesia is thought to result from neostriatal dopaminergic receptor supersensitivity induced by chronic treatment with neuroleptics. The authors suggest that dopaminergic supersensitivity also occurs in the mesolimbic region after chronic neuroleptic exposure, resulting in the development of a supersensitivity psychosis. Neuroleptic-induced supersensitivity psychosis is illustrated by data from 10 patients that demonstrate the syndrome's clinical and pharmacologic characteristics. An implication of neuroleptic-induced mesolimbic supersensitivity is that the tenaency toward psychotic relapse in such patients is determined by more than just the normal course of the illness.
11
Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains
Tyrone Lee, Philip Seeman, W. W. Tourtellotte et al. · Nature · 1978 · 352 citations
Medicine, Pharmacology, Psychiatry +10
H. Asper, Marco Baggiolini, Hans R. Bürki et al. · European Journal of Pharmacology · 1973 · 257 citations
Medicine, Neuroscience, Pharmacology +13
Advances in Biochemical Psychopharmacology vol 1.
Marc Goldstein · Archives of Neurology · 1970 · 236 citations